Modern H1-antihistamines in asthma

Drug Discovery Today: Therapeutic Strategies

Volumn 3, Issue 3, 2006, Pages 253-259

  Borade, Prashant S ^a   Ballary, Chetna C ^a   Currie, Graeme P ^b   Lee, Daniel K C ^c  

^a IPSWICH HOSPITAL   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; ASTEMIZOLE; AZELASTINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROMPHENIRAMINE; CELL ADHESION MOLECULE; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; CYTOKINE; DESLORATADINE; EBASTINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LORATADINE; MIZOLASTINE; MONTELUKAST; OXATOMIDE; PHENIRAMINE; PLACEBO; PSEUDOEPHEDRINE; SUPEROXIDE; TERFENADINE; TRIPROLIDINE; UNINDEXED DRUG;

ALLERGIC RHINITIS; ANTICHOLINERGIC EFFECT; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BASOPHIL; BLOOD BRAIN BARRIER; BRONCHODILATATION; BRONCHOSPASM; CHEMOTAXIS; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; GUINEA PIG; HEART DISEASE; HISTAMINE RELEASE; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LUNG FUNCTION; LUNG LAVAGE; MAST CELL; MEDIATOR RELEASE; NEUROLOGIC DISEASE; NONHUMAN; PATHOLOGICAL ANATOMY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEVERE PERSISTENT ASTHMA; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33751169592     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2006.08.005     Document Type: Review

References (35)

1. Gelfand E.W. Role of histamine in the pathophysiology of asthma: immunomodulatory and antiinflammatory activities of H1-receptor antagonists. Am. J. Med. 113 (2002) 2S-7S
2. 1-receptor antagonist) therapy useful in clinical asthma?. Clin. Exp. Allergy 29 Suppl. 3 (1999) 98-104
3. Malick A., and Grant J.A. Antihistamines in the treatment of asthma. Allergy 52 Suppl. 34 (1997) 55-66
4. Larsen J.S. Do antihistamines have a role in asthma therapy?. Pharmacotherapy 21 3 Pt 2 (2001) 28S-33S
5. Walsh G.M., et al. New insights into the second generation antihistamines. Drugs 61 (2001) 207-236
6. Walsh G.M. The clinical relevance of the anti-inflammatory properties of antihistamines. Allergy 55 Suppl. 60 (2000) 53-61
7. Golightly L.K., and Greos L.S. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs 65 (2005) 341-384
8. Philpot E.E. Safety of second-generation antihistamines. Allergy Asthma Proc. 21 (2000) 15-20
9. Simons F.E.R. Advances in H1-antihistamines. N. Engl. J. Med. 351 (2004) 2203-2217
10. MacGlashan Jr. D. Histamine: a mediator of inflammation. J. Allergy Clin. Immunol. 112 (2003) S53-S59
11. Casale T.B., and Dykewicz M.S. Clinical implications of the allergic rhinitis-asthma link. Am. J. Med. Sci. 327 (2004) 127-138
12. Simons F.E.R. What's in a name? The allergic rhinitis-asthma connection. Clin. Exp. All Rev. 3 (2003) 9-17
13. Kay G.G. The effects of antihistamines on cognition and performance. J. Allergy Clin. Immunol. 105 6 Pt 2 (2000) S622-S627
14. Hayashi S., and Hashimoto S. Anti-inflammatory actions of new antihistamines. Clin. Exp. Allergy 29 (1999) 1593-1596
15. Assanasen P., and Naclerio R.M. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin. Allergy Immunol. 17 (2002) 101-139
16. Nelson H.S. Prospects for antihistamines in the treatment of asthma. J. Allergy Clin. Immunol. 112 (2003) S96-S100
17. Agrawal D.K. Anti-inflammatory properties of desloratadine. Clin. Exp. Allergy 34 (2004) 1342-1348
18. Wilson A.M. Are antihistamines useful in managing asthma?. Curr. Opin. Allergy Clin. Immunol. 2 (2002) 53-59
19. Gelfand E.W., et al. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research. Curr. Med. Res. Opin. 20 (2004) 73-81
20. Gelfand E.W., et al. Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J. Allergy Clin. Immunol. 110 (2002) 85-95
21. Ciprandi G., et al. Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. J. Allergy Clin. Immunol. 112 4 Suppl. (2003) S78-S82
22. Ying S., and Meng Q. The effect of levocetirizine on histamine and cytokine induced up regulation of eotaxin by endothelial cells. Allergy 57 Suppl. 73 (2002) 145
23. Arnold R., et al. Levocetirizine modulates inflammatory responses of human neutrophils in the presence of the respiratory syncytial virus. Allergy 57 Suppl. 73 (2002) 146
24. Ciprandi G., et al. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin. Exp. Allergy 34 (2004) 958-964
25. Thomson L., et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin. Exp. Allergy 32 (2002) 1187-1192
26. Wu P., et al. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin. Exp. Allergy 35 (2005) 1073-1079
27. Baena-Cagnani C.E. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma. Allergy 56 Suppl. 65 (2001) 21-27
28. Berger W.E., et al., Desloratadine Study Group. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann. Allergy Asthma Immunol. 89 (2002) 485-491
29. Reinartz S.M., et al. Desloratidine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. Allergy 60 (2005) 1301-1307
30. Kaliner M., et al. Safety of fexofenadine HCl in asthmatic patients requiring inhaled corticosteroids in accordance with NHLBI guidelines [abstract]. J. Allergy Clin. Immunol. 1 (2000) S388
31. Lee D.K.C., et al. Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. Br. J. Clin. Pharmacol. 58 (2004) 34-39
32. Lee D.K.C., et al. Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma. J. Allergy Clin. Immunol. 111 (2003) 337-341
33. Davis B.E., et al. Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. J. Allergy Clin. Immunol. 116 (2005) 768-772
34. Lee D.K.C., et al. Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients. Chest 125 (2004) 1372-1377
35. Fardon T.C., et al. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. Ann. Allergy Asthma Immunol. 95 (2005) 259-265